NewcelX ( ($NCEL) ) has issued an announcement. On December 11, 2025, NewcelX Ltd. announced the publication of a patent application in China for ...
MedPage Today on MSN
They Need a Ventilator to Stay Alive. Getting One Can Be a Nightmare.
Many people permanently on ventilators prefer to live at home as long as they can. But care there can be perilous and pricey.
As the U.S. faces a shortage of special education workers, H.E.A.R.T.S Connection is providing support to the families of ...
Tired eyes, restless thoughts and books that finally make rest feel within reach. Calm guidance, steady pacing and ideas that ...
The scientist was famous for linking healing with storytelling. Sometimes that meant reshaping patients’ reality.
A sudden sensation of numbness? The nagging headache that just won't quit? That weird weakness in your leg? They're all ...
17don MSN
Civil rights leader Jesse Jackson leaves hospital after treatment for neurological disorder
The Rev. Jesse Jackson's family says that the civil rights leader has been released from a hospital where he was treated for a rare neurological disorder.
CHICAGO (AP) — The Rev. Jesse Jackson, who has been receiving around-the-clock care at home, has been hospitalized with a rare neurological disorder, according to his Chicago-based organization. The ...
NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China
NewcelX Ltd. (Nasdaq: NCEL), a next-generation biotechnology company developing advanced cell-therapy and neuroscience-driven ...
A new systematic analysis shows more than half the people living in the U.S., 54%, are affected by a neurological disease or disorder. Disorders of the nervous system impacted more than 180 million of ...
2don MSN
Genetic overlap of 14 psychiatric disorders explains why patients often have multiple diagnoses
An international collective of researchers is delivering new insights into why having multiple psychiatric disorders is the ...
BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, focused on development of BETR-001, its proprietary non-hallucinogenic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results